MedPath

Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions

Phase 2
Completed
Conditions
Constipation
Interventions
Other: Placebo
Registration Number
NCT01834729
Lead Sponsor
Mayo Clinic
Brief Summary

This study is designed to better understand the effects of effects of stress, relaxation, and a medication alfuzosin on bowel control and emptying in healthy people and patients with bowel problems.

Detailed Description

Normally, bowel emptying requires relaxation of the anal sphincter (i.e., lowermost end of intestinal tract) and pelvic muscles. Some people cannot relax these muscles normally and experience constipation. Alfuzosin is a medication which is approved to treat bladder but not bowel problems.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
74
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboSubjects randomized to this arm will receive a single placebo capsule identical to the study drug.
AlfuzosinAlfuzosinIn Part A, subjects randomized to this arm will receive a single dose of oral alfuzosin immediate release (IR) 2.5 mg. In Part B, only constipated patients will receive oral alfuzosin (10 mg extended release (ER)) capsules.
Primary Outcome Measures
NameTimeMethod
Weekly Rate of Spontaneous Bowel Movements at 4 Weeks4 weeks

A bowel movement is considered a spontaneous bowel movement (SBM) if no laxative, enema, or suppository was taken in the preceding 24 hours.

Weekly Rate of Complete Spontaneous Bowel Movements at 4 Weeks4 weeks

If the subject indicates that the spontaneous bowel movement (SBM) was associated with a sensation of complete bowel emptying, the SBM will be counted as a complete spontaneous bowel movement (CSBM).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic Rochester

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath